Managers / Q3 2019 · view latest →
Fernwood Investment Management, LLC
CIK 0001570296 · 400 CROWN COLONY, SUITE 101, QUINCY, MA, 02169 · 617-376-4750
Summary
Fernwood Investment Management, LLC reported $202M in U.S.-listed holdings across 180 positions for Q3 2019.
Its largest position, Global Blood Therapeutics Inc Com, represents 7.9% of the portfolio.
Compared with Q2 2019, the fund opened 39 new positions and exited 11.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 68.6% · $138M
- ETP · 24.6% · $50M
- REIT · 3.0% · $6M
- Royalty Trst · 1.9% · $4M
- ADR · 1.1% · $2M
- Other · 0.8% · $2M
Quarter-over-Quarter Changes full breakdown →
vs Q2 2019 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| BBIOBRIDGEBIO PHARMA INC COM | NEW | +95.2K | 95.2K | +$2M | $2M |
| SPYSPDR S&P 500 ETF | NEW | +5.9K | 5.9K | +$2M | $2M |
| BSXBOSTON SCIENTIFIC CORP | NEW | +31.1K | 31.1K | +$1M | $1M |
| WMTWALMART INC COM | NEW | +5.7K | 5.7K | +$681,000 | $681,000 |
| COUPA SOFTWARE INC COM | NEW | +5.3K | 5.3K | +$680,000 | $680,000 |
| JPMJPMORGAN CHASE & CO COM | NEW | +5.5K | 5.5K | +$643,000 | $643,000 |
| VHTVANGUARD HEALTH CARE INDEX FUND | NEW | +3.8K | 3.8K | +$635,000 | $635,000 |
| CAGCONAGRA BRANDS INC COM | NEW | +20.1K | 20.1K | +$617,000 | $617,000 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2019
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q4 2024 | $288M | 165 | Feb 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $307M | 189 | Oct 29, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $322M | 198 | Jul 31, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $343M | 720 | May 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $303M | 194 | Feb 5, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $278M | 190 | Nov 8, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $282M | 191 | Aug 9, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $261M | 184 | May 1, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $242M | 182 | Feb 7, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $237M | 185 | Nov 9, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $232M | 183 | Aug 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $285M | 200 | May 3, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $306M | 211 | Feb 9, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $291M | 198 | Oct 28, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $302M | 199 | Aug 5, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $272M | 190 | May 6, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $254M | 183 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $212M | 163 | Nov 3, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $202M | 166 | Aug 6, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $157M | 146 | Apr 30, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $209M | 159 | Feb 10, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $202M | 180 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $183M | 152 | Aug 1, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $187M | 155 | May 6, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $155M | 145 | Feb 12, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.